Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil

PLoS One. 2018 Nov 29;13(11):e0208211. doi: 10.1371/journal.pone.0208211. eCollection 2018.

Abstract

Background: In 2010, a ten-valent pneumococcal conjugate vaccine (PCV10) was introduced in the routine infant national immunization program in Brazil. Invasive pneumococcal disease (IPD) caused by serotype 19A (Spn19A) increased after the introduction of PCVs in several countries. We compared the frequency, antimicrobial resistance and molecular patterns of invasive Spn19A strains before and after PCV10 introduction in Brazil using data from the national laboratory-based surveillance.

Methods: We analyzed invasive Spn19A strains isolated from 2005-2009 (pre-PCV10 period), 2011-2015 and 2016-2017 (post-PCV10 periods). Antimicrobial susceptibility was performed for all Spn19A strains, and multilocus sequence typing (MLST) was performed for strains isolated in the age groups <5 years and ≥50 years.

Results: Among the study period, a total of 9,852 invasive Spn strains were analyzed, and 673 (6.8%) belonged to serotype 19A. Overall, the proportion of Spn19A among the total number of IPD strains increased from 2.8% in 2005-2009 to 7.0% and 16.4% in 2011-2015 and 2016-2017, respectively. The relative increase in Spn19A was observed especially in children <5 years old (2005-2009: 3.2%; 2011-2015: 15.5%; 2016-2017: 31.2%). The percentage of penicillin resistance (MIC 2.0-4.0 μg/mL), erythromycin resistance and multidrug resistance (MDR) increased after PCV10 introduction due to the expansion of the MDR clonal complex CC320 (2005-2009: 8.6%; 2011-2015: 56.1%; 2016-2017: 66.5%).

Conclusion: We observed an expansion of MDR-CC320 among invasive Spn19A strains after PCV10 introduction in Brazil, probably related to a combination of factors, such as vaccination and antimicrobial pressure. Continued surveillance of Spn19A strains is necessary to monitor the sustainability of this clonal complex in the Brazilian population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Typing Techniques
  • Brazil / epidemiology
  • Child
  • Child, Preschool
  • Drug Resistance, Bacterial
  • Drug Resistance, Multiple
  • Humans
  • Middle Aged
  • Multilocus Sequence Typing
  • Pneumococcal Infections / drug therapy
  • Pneumococcal Infections / epidemiology*
  • Pneumococcal Infections / prevention & control*
  • Pneumococcal Vaccines / therapeutic use*
  • Serogroup
  • Streptococcus pneumoniae / drug effects
  • Streptococcus pneumoniae / genetics
  • Streptococcus pneumoniae / isolation & purification*
  • Young Adult

Substances

  • 10-valent pneumococcal conjugate vaccine
  • Anti-Bacterial Agents
  • Pneumococcal Vaccines

Grants and funding

This study was financed by The São Paulo Research Foundation/FAPESP (grant to A.P. Cassiolato No. 13/03968-6), The Coordination for the Improvement of Higher Education Personnel/CAPES, The National Council for Scientific and Technological Development/CNPq [grants to M.C.C. Brandileone (Grant No. 304211/2014-1) and A.L. Andrade (Grant No. 306096/2010-2)] and Adolfo Lutz Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.